CorMedix
CRMD
31 hedge funds and large institutions have $40.4M invested in CorMedix in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.
851% more capital invested
Capital invested by funds: $4.25M → $40.4M (+$36.2M)
350% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 4
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
82% more funds holding
Funds holding: 17 → 31 (+14)
1.42% more ownership
Funds ownership: 1.99% → 3.41% (+1.4%)
31% less call options, than puts
Call options by funds: $3.02M | Put options by funds: $4.37M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
+$3.41M |
| 2 |
BG
Bollard Group
Boston,
Massachusetts
|
+$2.42M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$991K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$914K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$738K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.18M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$127K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$33K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.86K |
| 5 |
NPC
National Planning Corporation
El Segundo,
California
|
-$1.92K |
CRMD Hedge Fund Activity: Q1 2015 in Review
31 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2015, worth a combined $40.4M — up 851% from $4.25M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CRMD positions and 4 closed out — a net gain of 14 holders — while 9 added to existing stakes and 3 trimmed.
The largest buyer was Elliott Management, adding an estimated $3.41M. The largest seller was Millennium Management, cutting an estimated $2.18M.
- 31 institutional investors held CorMedix (CRMD) as of Q1 2015, up from 17 in Q4 2014.
- Funds reported $40.4M of CorMedix stock for Q1 2015, up 851% quarter-over-quarter.
- 18 funds opened new CorMedix positions in Q1 2015 and 4 closed out, a net change of +14 holders.
- The largest CorMedix buyer in Q1 2015 was Elliott Management, an estimated $3.41M added.
- The largest CorMedix seller in Q1 2015 was Millennium Management, an estimated $2.18M sold.
Based on aggregated 13F filings for Q1 2015.